RF | ||
---|---|---|
OUTLOOK RATING 1..100 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 28 | |
SMR RATING 1..100 | 5 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 52 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DVY | RF | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago67% |
Stochastic ODDS (%) | 2 days ago73% | 2 days ago76% |
Momentum ODDS (%) | 2 days ago87% | 2 days ago73% |
MACD ODDS (%) | 2 days ago90% | 2 days ago76% |
TrendWeek ODDS (%) | 2 days ago84% | 2 days ago66% |
TrendMonth ODDS (%) | 2 days ago75% | 2 days ago64% |
Advances ODDS (%) | 10 days ago85% | 9 days ago64% |
Declines ODDS (%) | 8 days ago80% | 13 days ago65% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago74% |
Aroon ODDS (%) | 2 days ago73% | 2 days ago51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLRG | 31.50 | 0.72 | +2.34% |
Fidelity U.S. Multifactor ETF | |||
XT | 54.83 | 1.23 | +2.29% |
iShares Exponential Technologies ETF | |||
BSTP | 31.06 | 0.52 | +1.71% |
Innovator Buffer Step-Up Strategy ETF | |||
IHE | 64.92 | 0.92 | +1.44% |
iShares US Pharmaceuticals ETF | |||
DFND | 38.80 | -0.95 | -2.39% |
Siren DIVCON Dividend Defender ETF |
A.I.dvisor indicates that over the last year, DVY has been closely correlated with BKH. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if DVY jumps, then BKH could also see price increases.
A.I.dvisor indicates that over the last year, RF has been closely correlated with HBAN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if RF jumps, then HBAN could also see price increases.